We are live on
!
Find out more
Balyasny Asset Management Portfolio holdings
AUM
$77.1B
1-Year Est. Return
42.89%
This Fund
S&P 500
This Quarter
Est. Return
+7.96%
1 Year Est. Return
+42.89%
3 Year Est. Return
+126.29%
5 Year Est. Return
+172.74%
10 Year Est. Return
+1,026.86%
AUM
$78.8B
AUM Growth
-$135M
(-0.17%)
Cap. Flow
-$4.13B
Cap. Flow
% of AUM
-5.25%
Top 10 Holdings %
Top 10 Hldgs %
14.64%
Holding
3,669
New
809
Increased
1,002
Reduced
1,102
Closed
643
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$807M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$497M |
| 3 |
RNAM
Avidity Biosciences
RNAM
|
+$390M |
| 4 |
Kenvue
KVUE
|
+$379M |
| 5 |
Broadcom
AVGO
|
+$324M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$409M |
| 2 |
Visa
V
|
+$354M |
| 3 |
Advanced Micro Devices
AMD
|
+$328M |
| 4 |
Meta Platforms (Facebook)
META
|
+$317M |
| 5 |
Lockheed Martin
LMT
|
+$316M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.61% |
| 2 | Consumer Discretionary | 9.64% |
| 3 | Healthcare | 8.17% |
| 4 | Industrials | 8.1% |
| 5 | Financials | 8.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1776
iBio
IBIO
$70M
| $2.12M | ﹤0.01% |
1,096,179
+1,085,779
| +10,440% | +$1.48M |
|
1777
CALL
Analog Devices
ADI
$187B
| $2.12M | ﹤0.01% |
7,800
-16,000
| -67% | -$4.02M |
|
|
AEXA
1778
American Exceptionalism Acquisition Corp
AEXA
$569M
| $2.11M | ﹤0.01% |
+185,683
| New | +$2.09M |
|
1779
Robinhood
HOOD
$87.4B
| $2.11M | ﹤0.01% |
+18,679
| New | +$2.43M |
|
1780
Seagate
STX
$216B
| $2.1M | ﹤0.01% |
7,632
-12,072
| -61% | -$3.13M |
|
1781
CALL
Veeva Systems
VEEV
$40.1B
| $2.1M | ﹤0.01% |
9,400
-86,900
| -90% | -$23.1M |
|
|
LB
1782
LandBridge Co
LB
$2.15B
| $2.09M | ﹤0.01% |
42,735
+22,099
| +107% | +$1.29M |
|
1783
Monopar Therapeutics
MNPR
$736M
| $2.08M | ﹤0.01% |
+31,907
| New | +$2.61M |
|
1784
EOG Resources
EOG
$74.8B
| $2.08M | ﹤0.01% |
19,830
-119,905
| -86% | -$12.9M |
|
1785
Envista
NVST
$4.54B
| $2.08M | ﹤0.01% |
95,726
-1,095,232
| -92% | -$22.5M |
|
1786
Amphastar Pharmaceuticals
AMPH
$887M
| $2.07M | ﹤0.01% |
77,467
-64,385
| -45% | -$1.66M |
|
1787
CALL
Samsara
IOT
$23.4B
| $2.07M | ﹤0.01% |
58,400
-19,300
| -25% | -$747K |
|
1788
MetLife
MET
$62.1B
| $2.07M | ﹤0.01% |
26,219
-74
| -0.3% | -$5.86K |
|
1789
James Hardie Industries
JHX
$17.9B
| $2.07M | ﹤0.01% |
99,708
-249,701
| -71% | -$5.01M |
|
1790
Dream Finders Homes
DFH
$1.38B
| $2.07M | ﹤0.01% |
120,770
+72,448
| +150% | +$1.48M |
|
1791
Bausch Health
BHC
$2.41B
| $2.06M | ﹤0.01% |
296,903
+277,527
| +1,432% | +$1.83M |
|
1792
CALL
PG&E
PCG
$39B
| $2.06M | ﹤0.01% |
128,400
| – | – |
|
|
PCSC
1793
DELISTED
Perceptive Capital Solutions
PCSC
| $2.06M | ﹤0.01% |
+158,000
| New | +$1.84M |
|
1794
CALL
GeneDx Holdings
WGS
$2.34B
| $2.05M | ﹤0.01% |
15,800
-1,700
| -10% | -$233K |
|
1795
Blue Owl Capital
OBDC
$5.81B
| $2.05M | ﹤0.01% |
164,548
-1,813,998
| -92% | -$23.1M |
|
1796
Cerence
CRNC
$402M
| $2.04M | ﹤0.01% |
191,286
+41,623
| +28% | +$457K |
|
1797
Canadian Imperial Bank of Commerce
CM
$113B
| $2.04M | ﹤0.01% |
+22,562
| New | +$1.94M |
|
1798
iShares MSCI Brazil ETF
EWZ
$8.54B
| $2.04M | ﹤0.01% |
64,262
-46,498
| -42% | -$1.47M |
|
1799
PUT
NXP Semiconductors
NXPI
$58.5B
| $2.04M | ﹤0.01% |
9,400
+1,700
| +22% | +$364K |
|
1800
Beyond Meat
BYND
$6.98B
| $2.04M | ﹤0.01% |
+82,845
| New | +$3.46M |
|
Similar funds
BC
Balyasny Asset Management's Q4 2025 Portfolio in Review
As of Q4 2025, Balyasny Asset Management held 3,669 positions worth $78.8B, down 0.17% from $78.9B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Balyasny Asset Management withdrew a net $4.13B in Q4 2025, closing 643 positions and reducing 1,102 holdings. Its most notable exit was Mr. Cooper, an estimated $277M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Balyasny Asset Management opened a new position in Avidity Biosciences worth $436M.
- Balyasny Asset Management's largest Q4 2025 buy was Avidity Biosciences: 6,040,590 shares worth $436M.
- Balyasny Asset Management added most to Amazon in Q4 2025, an estimated $807M increase.
- Balyasny Asset Management's biggest Q4 2025 reduction was Apple, cutting an estimated $409M.
- Balyasny Asset Management fully exited Mr. Cooper in Q4 2025, selling an estimated $277M.
- Balyasny Asset Management's ten largest holdings make up 15% of its $78.8B portfolio in Q4 2025.
- Balyasny Asset Management opened 809 new positions and closed 643 in Q4 2025.
- Balyasny Asset Management's portfolio value fell 0.17% quarter-over-quarter to $78.8B.
Based on Balyasny Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.